Lunsumio 1 mg concentrate for solution for infusion | medicines.ie

Company: Roche Registration GmbH
Active Ingredient: Mosunetuzumab
Strength: Mosunetuzumab: –
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence information is currently unavailable.

Roche Registration GmbH

3030 Lake Drive, Citywest Business Campus, Dublin 24, D24 KX6Y, Ireland

Email: ireland.druginfo@roche.com